STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

ALLO ALLOGENE THERAPEUTICS INCORPORATED StockScouter® Report

1

StockScouter® Score

ALLOGENE THERAPEUTICS INCORPORATED, a small cap company in the healthcare sector, is expected to underperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive

 

Concerns

  • Moving average analysis for ALLO suggests weak price movement over the medium term. Negative
  • Short-term relative price momentum exhibits meaningful weakness. Negative
  • The multi-period measure of relative price change and consistency is below average. Negative/Neutral

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 80% done.
Progress: 20% done.
Low
High

Core Model Grades

B
D
N/A
F

Previous Ratings

5
1
3